U.S. Building Stock News

Everpure earnings spark fresh interest Everpure (P) has drawn renewed attention after its fourth quarter fiscal 2026 earnings topped Wall Street expectations, a result that has sharpened the debate around growth potential and margin pressures. See our latest analysis for Everpure. The share price reaction has been steady rather than abrupt, with a 17.3% 1 month share price return around the earnings release. The 1 year total shareholder return of 49.7% and 5 year total shareholder return of...

If you are wondering whether Palo Alto Networks at around US$181 per share is offering good value right now, you are not alone. The stock has returned 1.4% over the last 7 days and 10.9% over the last 30 days, while the 1 year return stands at a 3.5% decline and the 3 year return is 96.9% with a 5 year return of 217.4%. Recent headlines have focused on Palo Alto Networks as a key name in cybersecurity, with ongoing attention on how its products fit into corporate security budgets. At the...

Why Sonos Stock Is On Investors’ Radar Now Sonos (SONO) is drawing attention after recent trading left the stock around $14.84, with performance over the past month, the past 3 months, and the past year giving investors fresh context for its current valuation. See our latest analysis for Sonos. The recent lift in Sonos’ 1 month share price return of 8.16% contrasts with its negative year to date share price return and mixed multi year total shareholder returns. This points to improving short...

In late April 2026, VSE Corporation sought stockholder approval to amend its Restated Certificate of Incorporation to authorize 10,000,000 shares of blank check preferred stock, aiming to enhance capital flexibility for M&A, capital structure optimization, and tailored investor financing ahead of a May 7, 2026 meeting. The proposal’s built-in safeguards, such as no preset superior voting rights, no current issuance plans, and required majority approval of all outstanding shares, highlight...

In late April and early May 2026, Fortinet released its 2026 Global Threat Landscape Report revealing a very large year-over-year jump in ransomware victims and rising AI-enabled cybercrime, while also preparing to report quarterly earnings on 6 May with analysts expecting higher earnings per share and revenue. The combination of Fortinet’s heightened role in global cybercrime disruption, including law-enforcement collaborations and a new Cybercrime Bounty program, and improving analyst...

Q1 2026 earnings snapshot for SPS Commerce (SPSC) SPS Commerce (SPSC) has opened 2026 with Q1 revenue of US$192.1 million, basic EPS of US$0.53 and net income of US$19.7 million, providing new information for shareholders watching the US$58.92 share price. Over recent periods, the company has reported revenue of US$170.9 million in Q4 2024 and US$192.1 million in Q1 2026, while trailing twelve month EPS is US$2.41 on net income of US$90.9 million. With earnings and margins already central to...

In late April 2026, Teledyne Technologies unified its ChartWorld and Raymarine Commercial operations under the Raymarine Commercial brand while also introducing advanced defense and imaging products such as the Prism C-UAS counter-drone software and the Caiman low-light imaging module. This combination of brand consolidation in maritime navigation and new high-performance sensing and defense solutions highlights Teledyne’s focus on integrated, system-level offerings across its core end...

UFC, part of TKO Group Holdings (NYSE:TKO), has agreed to host annual UFC Fight Nights in Baku, Azerbaijan. The multi year agreement runs through 2028 and establishes a recurring UFC event in the country. The partnership builds on Azerbaijan’s history of hosting major international sporting events. For TKO Group Holdings, which combines UFC and WWE, this Baku agreement fits into a broader push to deepen international reach in live combat sports and entertainment. UFC already runs events...

What recent price moves say about Essential Utilities Essential Utilities (WTRG) has seen its share price soften recently, with a 0.4% decline in the past day, 3.8% over the past week, and a 6.4% drop over the past month. See our latest analysis for Essential Utilities. That recent 6.4% 30 day share price return, alongside a 1.6% share price decline year to date and a 3.3% fall in the 1 year total shareholder return, suggests momentum has been fading both in the short term and over a longer...

Agnico Eagle Mines (NYSE:AEM) opened 2026 with Q1 revenue of US$4.1b and basic EPS of US$3.39, against a trailing twelve month revenue base of US$13.5b and EPS of US$10.66 that reflects strong earnings growth of 126.1% over the past year. Over recent quarters, revenue has moved from US$2.2b in Q4 2024 to US$2.5b, US$2.8b, US$3.1b and US$3.6b in 2025, before reaching US$4.1b in Q1 2026. Basic EPS has stepped from US$1.02 to US$1.62, US$2.13, US$2.10, US$3.04 and now US$3.39, with trailing net...

On April 17, William Blair initiated coverage on Enovis Corporation with an Outperform rating, emphasizing valuation opportunities and the importance of improving free cash flow conversion, while Vanguard disclosed a passive ownership stake above the 5% regulatory threshold. An interesting angle is William Blair’s support for Enovis’ more conservative 2026 growth outlook alongside management’s goal to lift free cash flow conversion from about 10% in 2025 to roughly 25% in 2026, sharpening...

Ecolab (ECL) is back in focus after recent trading pressure, with the stock down about 4% over the past week and roughly 8% over the past 3 months. This has prompted closer attention to its fundamentals. See our latest analysis for Ecolab. Recent trading pressure sits against a longer backdrop where the 1 year total shareholder return is 2.67%, while the 3 year figure is 54.20%. This suggests momentum has cooled in the short term. If you are comparing Ecolab with other opportunities in the...

Bio-Rad Laboratories (BIO) opened 2026 with Q1 revenue of US$592.1 million and a basic EPS loss of US$19.55, in a quarter where trailing twelve month EPS stood at US$6.24 on revenue of US$2.59 billion. The company has seen quarterly revenue move from US$585.4 million and EPS of US$2.29 in Q1 2025 to US$592.1 million and EPS of US$19.55 loss in Q1 2026. Over the same period, trailing twelve month net income shifted from a loss of US$2.16 billion in Q1 2025 to a profit of US$168.8 million in Q1...

What recent performance says about TG Therapeutics (TGTX) TG Therapeutics (TGTX) has drawn investor attention after a mixed stretch in the stock, with a small 1 day gain, a decline over the past week, and a positive move across the past 3 months. See our latest analysis for TG Therapeutics. At the current share price of $33.85, TG Therapeutics has a 90 day share price return of 15.02%, while the 1 year total shareholder return of 22.08% decline suggests recent momentum contrasts with longer...

What recent returns tell you about Parker-Hannifin (PH) Parker-Hannifin (PH) has drawn attention after a mixed run in its share price, with a 1 day return of about a 3% decline and a 7 day move of roughly a 9% decline challenging recent bullish sentiment. Over the past month and past 3 months, the stock shows declines of about 4% and 6% respectively, even as its 1 year total return stands at roughly 44%. This highlights a sharp contrast between short term volatility and longer term gains. See...

Vanguard has disclosed a substantial passive ownership stake in Magnolia Oil & Gas (NYSE:MGY), adding a major institutional holder to the company’s register. Magnolia has announced another annual dividend increase, marking its fifth consecutive year of raising the payout. These developments arrive as MGY trades around $30.09 and follows a 33.9% return year to date and 45.1% over the past year. For investors tracking NYSE:MGY, this mix of stronger institutional presence and a higher...

NPK International (NPKI) opened Q1 2026 with total revenue of US$75.1 million and basic EPS of US$0.12, as investors weighed the latest numbers against a year of forecasts calling for earnings and revenue growth. Over the past year, the company has seen revenue move from US$57.5 million in Q4 2024 to around US$75 million in Q1 2026, while quarterly EPS has shifted from US$0.09 to roughly US$0.12. This sets up a results season in which the key question is how sustainably those earnings...

If you are wondering whether AXT's share price still offers value after a huge run, the key is understanding what the current price actually reflects. AXT last closed at US$96.00, with returns of 26.1% over 7 days, 103.6% over 30 days and 472.8% year to date, while the 1 year return is very large at roughly 68x. These moves sit alongside multi year returns of 32x over 3 years and nearly 9x over 5 years, which keep the stock firmly on many investors' radars. This article is part of ongoing...

In late April 2026, Williams Companies approved a higher regular quarterly dividend of US$0.525 per share, or US$2.10 annualized, payable on June 29, 2026, to shareholders of record on June 12, 2026, marking a 5% increase from its 2025 payout. This dividend hike, combined with recent analyst upgrades praising Williams’ Transcontinental Gas Pipeline and power infrastructure exposure, underscores how income returns and core gas transmission assets sit at the center of the company’s current...

Atlassian (TEAM) just posted Q3 2026 results with revenue of US$1.8 billion, a basic EPS loss of US$0.38 and net income loss of US$98.4 million, setting the tone for another quarter where growth and profitability remain in tension. The company has seen quarterly revenue move from US$1.36 billion in Q3 2025 to US$1.79 billion in Q3 2026. Over that span, basic EPS ranged from a loss of US$0.27 in Q3 2025 to a loss of US$0.38 in the latest quarter, leaving investors focused squarely on how...

Praxis Precision Medicines stock overview Praxis Precision Medicines (PRAX) has drawn fresh attention as its clinical stage pipeline in central nervous system disorders remains in focus, prompting investors to reassess the stock after recent share price moves. See our latest analysis for Praxis Precision Medicines. Recent trading has been choppy, with a 1 day share price return of 1.68% and a 7 day share price return of 5.98% decline, while year to date momentum is positive and the 1 year...

Adient (ADNT) has given investors fresh news to assess, pairing the acquisition of a foam production plant in Romulus, Michigan with the commercialization of its new ProForce Massage Flow seating solution. See our latest analysis for Adient. Recent moves in operations and product development come as Adient’s share price sits at $21.32, with an 11.97% year to date share price return and a 67.22% total shareholder return over the past year, even as the 3 year and 5 year total shareholder...

Corvus Pharmaceuticals (CRVS) has drawn investor attention after appointing immunologist and drug development leader Dr. Andrew C. Chan to its Board of Directors. The move highlights the company’s focus on research driven decision making. See our latest analysis for Corvus Pharmaceuticals. The latest share price of US$15.46 comes after a mixed few months, with a 7.1% 30 day share price return set against a 25.3% decline over 90 days. At the same time, a year to date share price return of...

If you are wondering whether JPMorgan Chase is attractively priced or running ahead of its fundamentals, the current share level invites a closer look at what you are really paying for. At a last close of US$312.47, the stock has returned 1.4% over 7 days, 5.8% over 30 days, a negative 4.0% year to date, 26.2% over 1 year, 144.7% over 3 years and 119.9% over 5 years. This provides additional context for any assessment of value and risk. Recent coverage has focused on JPMorgan Chase as a...